Literature DB >> 32354772

Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept.

Pierre-Marie Duret1, Eden Sebbag2, Auriane Mallick3, Simon Gravier4, Lionel Spielmann3, Laurent Messer3.   

Abstract

Entities:  

Keywords:  antirheumatic agents; arthritis, infectious; biological therapy; spondylitis, ankylosing; tumour necrosis factor inhibitors

Year:  2020        PMID： 32354772     DOI： 10.1136/annrheumdis-2020-217362

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  32 in total

1.  COVID-19 in Immunocompromised Hosts: What We Know So Far.

Authors:  Monica Fung; Jennifer M Babik
Journal:  Clin Infect Dis       Date:  2020-06-27       Impact factor: 9.079

Review 2.  The Role of Cytokines and Chemokines in Severe Acute Respiratory Syndrome Coronavirus 2 Infections.

Authors:  Ren-Jun Hsu; Wei-Chieh Yu; Guan-Ru Peng; Chih-Hung Ye; SuiYun Hu; Patrick Chun Theng Chong; Kah Yi Yap; Jamie Yu Chieh Lee; Wei-Chen Lin; Shu-Han Yu
Journal:  Front Immunol       Date:  2022-04-07       Impact factor: 8.786

Review 3.  Coronavirus disease 2019 (COVID-19) in a patient with ankylosing spondylitis treated with secukinumab: a case-based review.

Authors:  Ilke Coskun Benlidayi; Behice Kurtaran; Emre Tirasci; Rengin Guzel
Journal:  Rheumatol Int       Date:  2020-06-26       Impact factor: 2.631

Review 4.  COVID-19 in Immunocompromised Hosts: What We Know So Far.

Authors:  Monica Fung; Jennifer M Babik
Journal:  Clin Infect Dis       Date:  2021-01-27       Impact factor: 20.999

5.  Olfactory and Gustatory Dysfunction in a COVID-19 Patient with Ankylosing Spondylitis Treated with Etanercept: Case Report.

Authors:  Jong Mok Lee; Sang Jin Lee
Journal:  J Korean Med Sci       Date:  2020-06-01       Impact factor: 2.153

Review 6.  Pathogenesis and Management of COVID-19.

Authors:  Khalid O Alfarouk; Sari T S AlHoufie; Samrein B M Ahmed; Mona Shabana; Ahmed Ahmed; Saad S Alqahtani; Ali S Alqahtani; Ali M Alqahtani; AbdelRahman M Ramadan; Mohamed E Ahmed; Heyam S Ali; Adil Bashir; Jesus Devesa; Rosa A Cardone; Muntaser E Ibrahim; Laurent Schwartz; Stephan J Reshkin
Journal:  J Xenobiot       Date:  2021-05-21

7.  TNF-α Blockers Showed Prophylactic Effects in Preventing COVID-19 in Patients with Rheumatoid Arthritis and Seronegative Spondyloarthropathies: A Case-Control Study.

Authors:  Mansour Salesi; Behrokh Shojaie; Ziba Farajzadegan; Naghmeh Salesi; Erfan Mohammadi
Journal:  Rheumatol Ther       Date:  2021-07-23

8.  Low symptomatic COVID-19 in an elderly patient with follicular lymphoma treated with rituximab-based immunotherapy: A case report.

Authors:  Stanisław Łącki; Kinga Wyżgolik; Michał Nicze; Sylwia Georgiew-Nadziakiewicz; Jerzy Chudek; Kamil Wdowiak
Journal:  World J Clin Cases       Date:  2021-06-26       Impact factor: 1.337

Review 9.  The signal pathways and treatment of cytokine storm in COVID-19.

Authors:  Lan Yang; Xueru Xie; Zikun Tu; Jinrong Fu; Damo Xu; Yufeng Zhou
Journal:  Signal Transduct Target Ther       Date:  2021-07-07

10.  Non-complicated evolution of COVID-19 infection in a patient with psoriasis and psoriatic arthritis during treatment with adalimumab.

Authors:  Mario Valenti; Paola Facheris; Giulia Pavia; Luigi Gargiulo; Riccardo Giovanni Borroni; Antonio Costanzo; Alessandra Narcisi
Journal:  Dermatol Ther       Date:  2020-06-26       Impact factor: 3.858
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.